Cambridge Healthtech Institute’s 8th Annual

Immuno-Oncology and Cell Therapy

February 16-17, 2021

 

While cancer immunotherapy has made a giant leap in the past decade, the majority of therapies at advanced stages of development are clustered in a similar target and mechanism space. The increased investment in immuno-oncology has created an urgent opportunity to discover and populate new target spaces and develop new modalities that either present new classes of immunotherapies or can be used in combination with existing products. The 8th Annual Immuno-Oncology and Cell Therapy meeting will bring together industry thought leaders from pharmaceutical and biotech companies and leading clinical centers to discuss emerging immuno-oncology targets, next-generation immunotherapies, combination strategies, and advances in cell therapy.   

 

Coverage will include, but is not limited to:

 

  • Immunomodulatory antibodies and bispecific antibodies for immunotherapy
  • Oncolytic virus immunotherapy
  • Adoptive cell therapy (CAR T, TCR, and TIL)       
  • Emerging IO targets and combinations
  • Off-the-shelf, allogeneic cell therapy
  • Immunotherapy targeting solid tumors
  • Genetic engineering approaches in cell therapy
  • Neoantigen-targeted therapies and personalized vaccines

 

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is September 18, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Jon Stroup

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5483 Email: jstroup@healthtech.com


Premier Sponsors

NeoGenomics

Seegene